Literature DB >> 31597740

TNF receptor 2 signaling prevents DNA methylation at the Foxp3 promoter and prevents pathogenic conversion of regulatory T cells.

Wen-Yi Tseng1,2, Yi-Shu Huang1,3, Felix Clanchy1, Kay McNamee1, Dany Perocheau1, Joy Ogbechi1, Shue-Fen Luo3, Marc Feldmann4, Fiona E McCann4, Richard O Williams4.   

Abstract

Regulatory T (Treg) cells expressing the transcription factor Foxp3 play an important role in maintaining immune homeostasis. Chronic inflammation is associated with reduced Foxp3 expression, function, and loss of phenotypic stability. Previous studies have established the importance of TNF receptor 2 (TNFR2) in the generation and/or activation of Treg cells. In this study, we assess the importance of TNFR2 in healthy mice and under inflammatory conditions. Our findings reveal that, in health, TNFR2 is important not only for the generation of Treg cells, but also for regulating their functional activity. We also show that TNFR2 maintains Foxp3 expression in Treg cells by restricting DNA methylation at the Foxp3 promoter. In inflammation, loss of TNFR2 results in increased severity and chronicity of experimental arthritis, reduced total numbers of Treg cells, reduced accumulation of Treg cells in inflamed joints, and loss of inhibitory activity. In addition, we demonstrate that, under inflammatory conditions, loss of TNFR2 causes Treg cells to adopt a proinflammatory Th17-like phenotype. It was concluded that TNFR2 signaling is required to enable Treg cells to promote resolution of inflammation and prevent them from undergoing dedifferentiation. Consequently, TNFR2-specific agonists or TNF1-specific antagonists may be useful in the treatment of autoimmune disease.

Entities:  

Keywords:  DNA methylation; FoxP3; regulatory T cells; rheumatoid arthritis; tumor necrosis factor receptor 2

Year:  2019        PMID: 31597740      PMCID: PMC6815167          DOI: 10.1073/pnas.1909687116

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  19 in total

1.  Lasker Clinical Medical Research Award. TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases.

Authors:  Marc Feldmann; Ravinder N Maini
Journal:  Nat Med       Date:  2003-10       Impact factor: 53.440

2.  DNA methylation controls Foxp3 gene expression.

Authors:  Julia K Polansky; Karsten Kretschmer; Jennifer Freyer; Stefan Floess; Annette Garbe; Udo Baron; Sven Olek; Alf Hamann; Harald von Boehmer; Jochen Huehn
Journal:  Eur J Immunol       Date:  2008-06       Impact factor: 5.532

3.  SOCS1 hypermethylation mediated by DNMT1 is associated with lipopolysaccharide-induced inflammatory cytokines in macrophages.

Authors:  Chang Cheng; Cheng Huang; Tao-Tao Ma; Er-Bao Bian; Yong He; Lei Zhang; Jun Li
Journal:  Toxicol Lett       Date:  2014-01-17       Impact factor: 4.372

4.  The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3.

Authors:  C L Bennett; J Christie; F Ramsdell; M E Brunkow; P J Ferguson; L Whitesell; T E Kelly; F T Saulsbury; P F Chance; H D Ochs
Journal:  Nat Genet       Date:  2001-01       Impact factor: 38.330

5.  Selective tumor necrosis factor receptor I blockade is antiinflammatory and reveals immunoregulatory role of tumor necrosis factor receptor II in collagen-induced arthritis.

Authors:  Fiona E McCann; Dany P Perocheau; Gerhard Ruspi; Katrina Blazek; Marie L Davies; Marc Feldmann; Jonathan L E Dean; A Allart Stoop; Richard O Williams
Journal:  Arthritis Rheumatol       Date:  2014-10       Impact factor: 10.995

Review 6.  TRAF2 multitasking in TNF receptor-induced signaling to NF-κB, MAP kinases and cell death.

Authors:  Alice Borghi; Lynn Verstrepen; Rudi Beyaert
Journal:  Biochem Pharmacol       Date:  2016-03-16       Impact factor: 5.858

7.  Transmembrane TNF-TNFR2 Impairs Th17 Differentiation by Promoting Il2 Expression.

Authors:  Patrick G Miller; Michael B Bonn; Susan C McKarns
Journal:  J Immunol       Date:  2015-08-12       Impact factor: 5.422

8.  Novel strategies to mimic transmembrane tumor necrosis factor-dependent activation of tumor necrosis factor receptor 2.

Authors:  Roman Fischer; Jessica Marsal; Cristiano Guttà; Stephan A Eisler; Nathalie Peters; John R Bethea; Klaus Pfizenmaier; Roland E Kontermann
Journal:  Sci Rep       Date:  2017-07-26       Impact factor: 4.379

9.  Intrinsic TNFR2 signaling in T regulatory cells provides protection in CNS autoimmunity.

Authors:  Kamar-Sulu N Atretkhany; Ilgiz A Mufazalov; Josefine Dunst; Anna Kuchmiy; Violetta S Gogoleva; David Andruszewski; Marina S Drutskaya; Denise L Faustman; Marius Schwabenland; Marco Prinz; Andrey A Kruglov; Ari Waisman; Sergei A Nedospasov
Journal:  Proc Natl Acad Sci U S A       Date:  2018-11-29       Impact factor: 11.205

10.  A TNFR2-Agonist Facilitates High Purity Expansion of Human Low Purity Treg Cells.

Authors:  Xuehui He; Sija Landman; Stijn C G Bauland; Juliette van den Dolder; Hans J P M Koenen; Irma Joosten
Journal:  PLoS One       Date:  2016-05-25       Impact factor: 3.240

View more
  29 in total

1.  TNF-TNFR2 Signal Plays a Decisive Role in the Activation of CD4+Foxp3+ Regulatory T Cells: Implications in the Treatment of Autoimmune Diseases and Cancer.

Authors:  Md Sahidul Islam; Yang Yang; Xin Chen
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Single cell analysis of spondyloarthritis regulatory T cells identifies distinct synovial gene expression patterns and clonal fates.

Authors:  Davide Simone; Frank Penkava; Anna Ridley; Stephen Sansom; M Hussein Al-Mossawi; Paul Bowness
Journal:  Commun Biol       Date:  2021-12-14

3.  A TNFR2 antibody by countering immunosuppression cooperates with HMGN1 and R848 immune stimulants to inhibit murine colon cancer.

Authors:  Mengmeng Jiang; Jia Liu; Debra Tross; Ping Li; Fengyang Chen; Md Masud Alam; Denise L Faustman; Joost J Oppenheim; Xin Chen
Journal:  Int Immunopharmacol       Date:  2021-11-15       Impact factor: 4.932

Review 4.  Medical Treatment Can Unintentionally Alter the Regulatory T-Cell Compartment in Patients with Widespread Pathophysiologic Conditions.

Authors:  Sabrina N Copsel; Thomas R Malek; Robert B Levy
Journal:  Am J Pathol       Date:  2020-08-01       Impact factor: 4.307

Review 5.  Clinical value of DNA methylation markers in autoimmune rheumatic diseases.

Authors:  Esteban Ballestar; Amr H Sawalha; Qianjin Lu
Journal:  Nat Rev Rheumatol       Date:  2020-08-05       Impact factor: 20.543

Review 6.  Insights into the biology and therapeutic implications of TNF and regulatory T cells.

Authors:  Benoit L Salomon
Journal:  Nat Rev Rheumatol       Date:  2021-07-05       Impact factor: 20.543

7.  Pharmacological modulation of T cell immunity results in long-term remission of autoimmune arthritis.

Authors:  Yi-Shu Huang; Wen-Yi Tseng; Felix I L Clanchy; Louise M Topping; Joy Ogbechi; Kay McNamee; Dany Perocheau; Nien-Yi Chiang; Peter Ericsson; Anette Sundstedt; Zhong-Tian Xue; Leif G Salford; Hans-Olov Sjögren; Trevor W Stone; Hsi-Hsien Lin; Shue-Fen Luo; Richard O Williams
Journal:  Proc Natl Acad Sci U S A       Date:  2021-05-11       Impact factor: 11.205

Review 8.  Interleukin-2 and regulatory T cells in rheumatic diseases.

Authors:  Antonios G A Kolios; George C Tsokos; David Klatzmann
Journal:  Nat Rev Rheumatol       Date:  2021-11-02       Impact factor: 20.543

9.  TNFR2/14-3-3ε signaling complex instructs macrophage plasticity in inflammation and autoimmunity.

Authors:  Wenyu Fu; Wenhuo Hu; Young-Su Yi; Aubryanna Hettinghouse; Guodong Sun; Yufei Bi; Wenjun He; Lei Zhang; Guanmin Gao; Jody Liu; Kazuhito Toyo-Oka; Guozhi Xiao; David B Solit; Png Loke; Chuan-Ju Liu
Journal:  J Clin Invest       Date:  2021-08-16       Impact factor: 14.808

10.  Comparative Analysis on Abnormal Methylome of Differentially Expressed Genes and Disease Pathways in the Immune Cells of RA and SLE.

Authors:  Qinghua Fang; Tingyue Li; Peiya Chen; Yuzhe Wu; Tingting Wang; Lixia Mo; Jiaxin Ou; Kutty Selva Nandakumar
Journal:  Front Immunol       Date:  2021-05-17       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.